Marshall Wace’s ALX Oncology ALXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.6K | Sell |
106,280
-164,917
| -61% | -$69.3K | ﹤0.01% | 2455 |
|
|
2025
Q1 | $168K | Buy |
+271,197
| New | +$168K | ﹤0.01% | 2305 |
|
|
2024
Q4 | – | Sell |
-160,059
| Closed | -$291K | – | 2355 |
|
|
2024
Q3 | $291K | Sell |
160,059
-475,620
| -75% | -$866K | ﹤0.01% | 1996 |
|
|
2024
Q2 | $3.83M | Buy |
635,679
+514,133
| +423% | +$3.1M | 0.01% | 1008 |
|
|
2024
Q1 | $1.36M | Buy |
121,546
+109,977
| +951% | +$1.23M | ﹤0.01% | 1331 |
|
|
2023
Q4 | $172K | Buy |
+11,569
| New | +$172K | ﹤0.01% | 1690 |
|
|
2023
Q2 | – | Sell |
-17,583
| Closed | -$79.5K | – | 1973 |
|
|
2023
Q1 | $79.5K | Buy |
+17,583
| New | +$79.5K | ﹤0.01% | 2017 |
|
|
2022
Q4 | – | Sell |
-24,177
| Closed | -$231K | – | 2296 |
|
|
2022
Q3 | $231K | Buy |
+24,177
| New | +$231K | ﹤0.01% | 2308 |
|
|
2022
Q1 | – | Sell |
-106,875
| Closed | -$2.3M | – | 2573 |
|
|
2021
Q4 | $2.3M | Buy |
+106,875
| New | +$2.3M | ﹤0.01% | 1567 |
|
|
2021
Q3 | – | Sell |
-18,021
| Closed | -$985K | – | 2358 |
|
|
2021
Q2 | $985K | Buy |
+18,021
| New | +$985K | ﹤0.01% | 1408 |
|